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REVIEW CURRENTOPINION LDL–cholesterol transport to the endoplasmic
reticulum: current concepts Copyright 
www.co-lipidology.comSimon G. Pfisterer, Johan Pera¨nen, and Elina IkonenPurpose of review
In this article, we summarize the present information related to the export of LDL-derived cholesterol from
late endosomes, with a focus on Nieman-Pick disease, type C1 (NPC1) cholesterol delivery toward the
endoplasmic reticulum (ER). We review data suggesting that several pathways may operate in parallel,
including membrane transport routes and membrane contact sites (MCSs).
Recent findings
There is increasing appreciation that MCSs provide an important mechanism for intermembrane lipid
transfer. In late endosome–ER contacts, three protein bridges involving oxysterol binding protein related
protein (ORP)1L-vesicle associated membrane protein-associated protein (VAP), steroidogenic acute
regulatory protein (StAR)D3-VAP and ORP5-NPC1 proteins have been reported. How much they contribute
to the flux of LDL–cholesterol to the ER is currently open. Studies for lipid transfer via MCSs have been most
advanced in Saccharomyces cerevisiae. Recently, a new sterol-binding protein family conserved between
yeast and man was identified. Its members localize at MCSs and were named lipid transfer protein
anchored at membrane contact sites (Lam) proteins. In yeast, sterol transfer between the ER and the yeast
lysosome may be facilitated by a Lam protein.
Summary
Increasing insights into the role of MCSs in directional sterol delivery between membranes propose that
they might provide routes for LDL–cholesterol transfer to the ER. Future work should reveal which specific
contacts may operate for this, and how they are controlled by cholesterol homeostatic machineries.
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Cholesterol is a vital constituent of mammalian cell
membranes, wherein it regulates membrane bio-
physical properties and functions of membrane-
associated proteins. Cholesterol is heterogeneously
distributed between membranes, being enriched
in the plasma membrane. In addition, cholesterol
is abundant in the endocytic recycling endosomes
and in the trans-Golgi-network (TGN) [1]. Instead,
the cholesterol content of the ER is low, and it is here
that the key regulatory machinery for sensing
and adjusting cellular cholesterol levels, the sterol
regulatory element-binding protein-SREBP cleav-
age-activating protein system, is localized [2].
The low ER cholesterol content is achieved by rapid
exchange to more cholesterol-rich membranes and
by esterification to a fatty acid by acyl-CoA choles-
terol acyl transferase, a.k.a. sterol O-acyl transferase,
followed by deposition of the produced cholesteryl
esters in lipid droplets [3].© 2016 Wolters Kluwer Apart from hepatic and central nervous system
cells (that are efficient in synthesizing cholesterol
de novo), cells acquire cholesterol mainly via recep-
tor-mediated uptake of LDL particles. LDL binds to
its receptor at the plasma membrane and is taken
up by clathrin-mediated endocytosis. In the acidic
pH of endosomes, LDL dissociates from its receptorHealth, Inc. All rights reserved.
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KEY POINTS
 LDL-derived late endosomal cholesterol may reach the
ER via several routes and membrane compartments,
including the plasma membrane.
 The late endosomal compartments receiving LDL–
cholesterol form numerous contacts with the ER.
 Several cholesterol-binding proteins localize to late
endosome–ER contact sites, but their mode of action is
still uncertain.
 A new evolutionarily conserved protein family, Lam
proteins, implicated in sterol transfer between ER and
late endosomal compartments in yeast, has recently
been identified.
LDL-cholesterol transport to the ER Pfisterer et al.that is recycled to the plasma membrane. LDL in
turn is delivered to late endosomal compartments
(here referred to as late endosomes) where esterified
cholesterol is hydrolyzed by lysosomal acid lipase.
The free cholesterol generated is thought to be
transferred by the soluble NPC2 protein in the late
endosome lumen to the membrane bound NPC1 Copyright © 2016 Wolters Kluwe
Lipoprotein uptake
Choleste
rol equilib
rati
Ra
b8a
/M
yo5
b/a
c
FIGURE 1. Delivery of LDL-cholesterol to the plasma membrane a
protrusion showing the positioning of marker proteins Cherry-CD6
(PM)] and BFP-KDEL [highlighting endoplasmic reticulum (ER)]. Rig
routes. Upon LDL endocytosis, LDL-cholesterol reaches multivesicul
via a Rab8a/Myo5b/actin-dependent vesicular trafficking pathwa
organelles, such as peroxisomes (P). PM cholesterol can be transp
cholesterol can also reach the ER via vesicular trafficking, involvin
transport between LE and ER at MCSs. These MCSs remain to be
proteins (see Table 1). BFP-KDEL was a gift from Gia Voeltz [44].
0957-9672 Copyright  2016 Wolters Kluwer Health, Inc. All rights resethat inserts it into the late endosomal membrane
for export [4–6]. What precisely happens after NPC1
has captured cholesterol and how the export of
LDL-cholesterol from late endosomes is achieved,
is less clear. For instance, the late endosomal
membrane protein, LAMP-2, is required for efficient
late endosome cholesterol export [7,8], but what its
specific role is, remains open.
Biochemical data indicate that two key desti-
nations for the LDL-derived cholesterol are the
plasmamembrane and the ER. Cholesterol transport
to the plasma membrane maintains plasma mem-
brane integrity and functions, whereas transport to
the ER is important for ER cholesterol sensing and
for providing a backup mechanism of cholesterol
storage. With this in mind, several transport routes
for LDL–cholesterol from late endosomes to the ER
have been proposed: transport first to the plasma
membrane and from there to the ER, trafficking
from late endosomes to sterol-enriched endomem-
branes, such as the Golgi, and from there via retro-
grade transport to the ER and transfer of cholesterol
from late endosomes directly to the ER (Fig. 1). The
first scenario might help to ensure sufficient choles-
terol supply to the plasma membrane prior tor Health, Inc. All rights reserved.
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Lipid metabolismdecreasing cholesterol production in the ER or
leading to its sequestration to lipid droplets. This
may also apply to the second scenario, as lipid
sorting, for example in the TGN can generate
cholesterol-enriched carriers targeted to the plasma
membrane [9]. On the other hand, an increasing
number of examples indicate that sterol transfer
can occur via direct late endosome–ER membrane
contact sites (MCSs) to facilitate targeted sterol
transfer between late endosomes and the ER
[10,11]. In the following, we will briefly discuss
these different routings, with emphasis on the most
recent literature regarding MCSs and their potential
roles, including new candidate proteins for late
endosome–ER cholesterol delivery.CHOLESTEROL TRANSPORT FROM LATE
ENDOSOMES TO THE ENDOPLASMIC
RETICULUM VIA PLASMA MEMBRANE OR
TRANS-GOLGI-NETWORK
A major fraction of LDL–cholesterol may initially
be transferred to the plasma membrane and surplus
plasma membrane cholesterol is then routed to
the ER. The interdependence of these routes is
supported by observations that LDL–cholesterol
loading stimulates the esterification of plasmamem-
brane cholesterol [12,13]. Furthermore, extraction
of plasma membrane cholesterol in parallel to
stimulation of cholesterol transfer toward the ER
results in a drastic reduction of cholesterol reaching
the ER [13]. A recent study identified three different
cholesterol pools in the plasma membrane:
an essential cholesterol pool needed to maintain
membrane integrity, a cholesterol pool shielded
via interaction with sphingomyelin and releasable
upon degradation of sphingomyelin, and a regulat-
ory cholesterol pool that accommodates incoming
LDL–cholesterol and can redirect cholesterol to the
ER [14]. This three pool-model would enable the
plasmamembrane to participate in the regulation of
cholesterol homeostasis without compromising
its major other functions.
How does LDL–cholesterol reach the plasma
membrane? We have provided evidence for a
Rab8a-dependent membrane recycling route that
directs LDL–cholesterol to the plasma membrane,
in particular to cell adhesion sites, thereby contribu-
ting to cell movement [15]. Late endosome-derived
cholesterol carriers apparently fuse with the plasma
membrane, but it is possible that this involves
prior communication, for example with recycling
endosomes. Interestingly, there is also recent
evidence for the involvement of late endosome-
peroxisome communication in LDL-cholesterol
delivery toward the plasma membrane [16]. Copyright © 2016 Wolters Kluwer 
284 www.co-lipidology.comHow plasma membrane cholesterol is trans-
ferred back to the ER remains enigmatic. There is
evidence that cytoplasmic sterol-binding proteins
(in particular, oxysterol-binding protein-related
oxysterol-binding homology (Osh) proteins in yeast
or ORP proteins in mammals) may contribute
but are probably not exclusively in charge, as
their depletion causes moderate effects on plasma
membrane–ER sterol transfer [17–19].
Plasma membrane independent transport of
LDL–cholesterol to the ER can bemediated by retro-
grade membrane trafficking from late endosomes
to the TGN. Depletion of key regulators of this
pathway reduced cholesterol arrival in the ER [20].
In support for this route, overexpression of Rab9,
which regulates late endosome to TGN transport,
could rescue late endosomal cholesterol accumu-
lation in NPC1-deficient cells and Rab9 silencing
leads to late endosomal cholesterol accumulation
[15,21,22]. Cholesterol should then take a retro-
grade Golgi to ER pathway to reach the ER. In fact,
overexpression of Rab6, involved in Golgi-ER trans-
port, can facilitate cholesterol esterification [23].
Notably, the sterol-binding protein oxysterol-bind-
ing protein can facilitate cholesterol transport ante-
rogradely from the ER to the Golgi at MCSs [24], but
whether a reverse transfer takes place is not clear.CHOLESTEROL TRANSPORT VIA LATE
ENDOSOME: ENDOPLASMIC RETICULUM
MEMBRANE CONTACT SITES
Apart from membrane transport, there is increasing
evidence for lipid exchange via transfer protein
complexes that bridge between twomembrane com-
partments and help to maintain membrane lipid
homeostasis. In these MCSs, the neighboring mem-
branes are within a short distance (up to 30nm),
with lipid transfer proteins concentrating at such
sites to facilitate directional lipid exchange [10,25].
Accumulating evidence indicates that this transfer
can take place as a countertransport of two lipid
species, for instance sterol and phosphoinositide
[24]. Especially the ER is known to form numerous
membrane contacts with other organelles including
the Golgi, mitochondria, plasma membrane
and endosomes [10,26]. Thus, MCSs between late
endosome and ER could potentially allow fast and
direct transfer of incoming LDL-derived cholesterol
to the ER.
Membrane contacts between the ER and
endosomes were visualized by three-dimensional
electron microscopy, and live cell microscopy
suggested that an astonishing 99% of late endo-
somes were in persistent association with the ER
[27]. Indeed, late endosomesmove along ER tubules,Health, Inc. All rights reserved.
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LDL-cholesterol transport to the ER Pfisterer et al.while connections between their membranes seem
to be maintained [27,28]. Furthermore, ER–late
endosome contacts regulate endosome fission
[29], linking sites of endosomal cargo sorting to
the ER. So far, two different mechanisms have been
proposed for late endosome–ER contact site for-
mation in conjunction with cholesterol sensing or
transfer. One involves late endosome–ER tethering
via interaction of the ER membrane protein VAP-A
with ORP1L or StARD3 in late endosome. The other
relies on interaction of ORP5 at the ER side with
NPC1 in the late endosome membrane (Table 1).
ORP1L and ORP5 bind cholesterol [32]. ORP1L
localizes to the late endosome-limiting membrane
and interacts with VAP in the ER, forming contact
sites [33] (Table 1). However, the ORP1L/VAP con-
tact site formation is enhanced under cholesterol
poor conditions [33,34]. This is counterintuitive
as one would expect that if these contacts represent
a late endosome–ER LDL–cholesterol transfer route,
they would be enhanced when late endosomes
are filled by incoming LDL–cholesterol. At present,
direct evidence for cholesterol transport at ORP1L/
VAP late endosome–ER contacts is lacking, and
ORP1L/VAP contacts have been proposed to act as
cholesterol sensors rather than actual cholesterol
transporters [33].
VAP also generates ER–late endosome contacts
via interaction with StARD3, another cholesterol-
binding protein embedded in the limiting mem-
brane of late endosome [35,36]. These contacts are
independent of ORP1L [37], implying that different
sterol-regulated late endosome–ER contacts exist,
presumably with different functions. Moreover,
ORP1L and StARD3 also target to different subsets
of late endosomes, with ORP1L present in more
mature late endosomes colocalizing with NPC1,
whereas StARD3 localizes to NPC1-negative late Copyright © 2016 Wolters Kluwe
Table 1. Late endosome–endoplasmic reticulum contact sites rela
Contact site formation via
Proof of contact
site localizationER LE
VAP-A ORP1L Electron microscopy,
only VAP-A
VAP-A StARD3 Electron microscopy
ORP5 NPC1 –
Lam6 Electron microscopy
ER, endoplasmic reticulum; LE, late endosome; NPC1, Nieman-Pick disease, type C1
protein related protein 1L; StARD3, Steroidogenic acute regulatory protein; VAP, ve
0957-9672 Copyright  2016 Wolters Kluwer Health, Inc. All rights reseendosomes [38]. Overexpression of StARD3 stimu-
lates the formation of late endosome–ER contact
sites, and it was suggested that StARD3/VAP
contacts are involved in cholesterol transport or
cholesterol sensing at late endosome–ER contact
sites [37]. However, StARD3 silencing does not result
in cholesterol accumulation in late endosomes or
disruption of cholesterol transport toward the ER
[36]. Also, StARD3 overexpression does not promote
cholesterol transport toward the ER [39] but rather
toward the plasma membrane, with concomitant
cholesterol depletion in the ER [40].
Thus, although the topologies of the choles-
terol-binding domains in both StARD3 and ORP1L
are correct for sterol export from late endosome,
firm evidence for their role in LDL–cholesterol
transport to the ER is missing. It is possible that
the physiological context in which ORP1L and
StARD3 function as cholesterol transporters or
sensors is more specialized than that of ‘bulk’
LDL–cholesterol delivery to the ER, but this context
has yet to be identified. On the basis of available
evidence, it would be equally possible that StARD3/
VAP and ORP1L/VAP contacts are involved, for
example in the delivery of de-novo synthesized
cholesterol from the ER to late endosomes and that
expansion of the late endosome–ER contact sites
under these conditions might ensure efficient
sterol transport.
A third characterizedmolecular bridge between
ER and late endosomes involves the cholesterol-
binding proteins ORP5 in the ER interacting with
NPC1 in the late endosomal membrane (Table 1).
ORP5 depletion was reported to result in late
endosomal cholesterol accumulation and inhibit
LDL–cholesterol esterification similarly as NPC1,
placing it as a potential downstream effector of
NPC1 [30]. Yet, the effect of ORP5 silencing onr Health, Inc. All rights reserved.
ted to cholesterol sensing or trafficking
Evidence for cholesterol transport at late endo-
some–endoplasmic reticulum contacts
–
–
ORP5 depletion results in LE cholesterol accumulation
and impaired cholesterol esterification [30]
Lam6 is required for the formation of sterol-enriched
domains in the vacuole. Shifting Lam6 to ER/
vacuole contact sites increases vacuolar sterol rich
domains [31&]
; ORP5, oxysterol binding protein related protein 5; ORP1L, oxysterol binding
sicle associated membrane protein-associated protein.
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Lipid metabolismlate endosomal cholesterol accumulation appears
less evident than that induced by NPC1 depletion
(Pfisterer, Ho¨ltta¨-Vuori and Ikonen, unpublished
observations). Moreover, recent evidence points
to a role of ORP5 in the ER–plasma membrane
countertransport of phosphatidylserine and phos-
phatidylinositol phosphate [41
&
], which needs to
be reconciled with the possible late endosome–ER
cholesterol transfer function of the protein.
Whether ORP5 facilitates cholesterol transport
via late endosome–ER contact sites and whether
indeed ORP5 and NPC1 are present in late
endosome–ER contact sites warrant further
investigation.NEW PROTEINS IN INTERMEMBRANE
STEROL TRANSPORT
Recently, a new sterol-binding protein family was
identified that was found to localize at MCSs and
named the lipid transfer protein anchored at
membrane contact sites (Lam) family [42
&
]. It
contains three family members in humans and six
in S. cerevisiae. So far, most of our knowledge on Lam
proteins comes from yeast. Lam2 (Ysp2 is the other
name for this protein in yeast), 4 and 6 (lipid transfer
at contact site 1) have been shown either to bind
sterol or facilitate cholesterol transfer via their
conserved StART domains [42
&
,31
&
]. Interestingly,
Lam6 localizes at intracellular MCSs, including
ER–vacuole (yeast lysosome) and ER–mitochondria
[ER-mitochondria encounter structure (ERMES)]
contacts [31
&
,43
&
], and Lam6 overexpression can
expand MCSs [43
&
]. The first evidence for the
involvement of Lam6 in ER–vacuole sterol transfer
comes from observations that Lam6 deletion
reduces the formation of sterol-enriched domains
in the vacuole. Conversely, Lam6 targeting to
ER–vacuole contact sites via disruption of ERMES
contacts increases sterol-enriched domains at the
vacuole, suggesting that Lam6 stimulates sterol
transfer from the ER to the vacuole [31
&
].
Additional evidence for the involvement
of Lam proteins in sterol transfer comes from studies
of Lam1 (Ysp1), 2 and 3 (Sip3) that localize to
ER–plasma membrane contact sites. Individual
deletions of these proteins reduce transport of
exogenously added sterols from the plasma mem-
brane toward the ER by up to 50%which is similar to
that observed by simultaneous deletion of all Osh
proteins [17,42
&
].
So far, Lam6 is the first example for sterol
transfer at ER–vacuole contact sites in S. cervisiae
(Table 1). Given the importance of cholesterol trans-
fer between late endosomes and the ER in mamma-
lian cells, human Lam proteins are emerging as Copyright © 2016 Wolters Kluwer 
286 www.co-lipidology.comfascinating targets for future investigation. To date,
the human Lam proteins hLam-a, b, c (also named
GramD1a, b, c) remain uncharacterized. It has been
suggested that the StART domain of hLam-a has
sterol transfer activity in S. cerevisiae [42
&
], implying
that the functions of Lam proteins are evolutionar-
ily conserved. Whereas hLam-a mRNA displays a
relatively uniform expression pattern across differ-
ent tissues, hLam-b transcript is more abundantly
expressed in steroidogenic tissue, opening the
possibility that it might play a role in cholesterol
transfer at ER–mitochondrial contact sites
contributing to steroidogenesis.CONCLUSION
Although NPC1 represents a key gatekeeper
protein in LDL–cholesterol transport, there are
probably several downstream effectors of NPC1
that may play redundant roles in delivering
LDL-derived cholesterol further. For example, no
single major pathway of LDL–cholesterol transport
to the ER has been identified. There is increasing
evidence that MCSs facilitate lipid transfer
between juxtaposed membranes. When it comes
to late endosome–ER contacts, three molecularly
distinct protein bridges involving sterol-binding
proteins have been reported: via ORP1L-VAP,
StARD3-VAP or ORP5-NPC1 proteins. However,
for ORP1L and StARD3-dependent contacts,
the available evidence rather disfavors their
contribution in LDL–cholesterol delivery to the
ER, and for ORP5 contacts, the evidence awaits
confirmation. Studies for lipid transfer via MCSs
have been most advanced in S. cerevisiae. Although
sterol fluxes are somewhat different in yeast
because of lack of lipoprotein sterol uptake,
the basic mechanisms of lipid transfer are likely
conserved. The recent characterization of a
novel protein family with members containing
a sterol-binding domain and localizing at MCSs
has pinpointed the first yeast protein, Lam6,
potentially operating in sterol transfer at ER–
vacuole contacts. What role(s) the human Lam
homologs play in cellular cholesterol delivery will
be an interesting new avenue of research.
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